Toxicity of ochratoxin A and its modulation by antioxidants: A review

Toxins

Volumn 5, Issue 10, 2013, Pages 1742-1766

  Sorrenti, Valeria ^a   Di Giacomo, Claudia ^a   Acquaviva, Rosaria ^a   Barbagallo, Ignazio ^a   Bognanno, Matteo ^b   Galvano, Fabio ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

Author keywords

Antioxidants; DNA damage; Ochratoxin A; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CATECHOL DERIVATIVE; GLUTATHIONE; GLYCYRRHIZA EXTRACT; GLYCYRRHIZA GLABRA EXTRACT; LYCOPENE; MELATONIN; OCHRATOXIN; OXYGEN RADICAL; PHENOL DERIVATIVE; UBIDECARENONE; VITAMIN; VITIS VINIFERA EXTRACT; ZINC;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; CARCINOGENICITY; CYTOTOXICITY; DNA DAMAGE; FOOD COMPOSITION; FOOD CONTAMINATION; FOOD POISONING; GENOTOXICITY; HUMAN; KIDNEY CARCINOMA; KIDNEY INJURY; LC 50; LIPID PEROXIDATION; LIVER CELL CARCINOMA; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; REPRODUCTIVE TOXICITY; REVIEW; TOXIN STRUCTURE;

ANIMALS; ANTIOXIDANTS; CARCINOGENS; DIET; HUMANS; NEOPLASMS; OCHRATOXINS;

EID: 84886566432     PISSN: 20726651     EISSN: None     Source Type: Journal    
DOI: 10.3390/toxins5101742     Document Type: Review

References (167)

1. Binder, E.M. Managing the risk of mycotoxins in modern feed production. Anim. Feed Sci. Technol. 2007, 133, 149-166.
2. Sweeney, M.J.; Dobson, A.D.W. Mycotoxin production by Aspergillus, Fusarium and Penicillium species. Int. J. Food Microbiol. 1998, 43, 141-158.
3. Bryden, W.L. Mycotoxins and Animal Production: Insidious Problems Associated with Contaminated Feedstuffs. In Proceedings of the International Symposium on Recent Advances in Animal Nutrition, Kuala Lumpur, Malaysia, 2004.
4. Bryden, W.L. Mycotoxin contamination of the feed supply chain: Implications for animal productivity and feed security. Anim. Feed Sci. Technol. 2012, 173, 134-158.
5. Oswald, I.P.; Marin, D.E.; Bouhet, S.; Pinton, P.; Taranu, I.; Accensi, F. Immunotoxicological risk of mycotoxins for domestic animals. Food Addit. Contam. 2005, 22, 354-360.
6. International Agency for Research on Cancer (IARC). Some Naturally Occurring Substances: Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans; IARC: Lyon, France, 1993; Volume 56.
7. FAO/WHO. Joint FAO/WHO Conference on Food Additives, Food and Agriculture Organization of the United Nations, Rome, Italy, 1956; FAO Nutrition Meetings Report Series, No. 11; World Health Organization, Geneva, Switzerland, 1956; WHO Technical Report Series, No. 107.
8. JECFA. Evaluation of Certain Food Additives and Contaminants: Ochratoxin A; WHO Technical Report Series 806; WHO: Geneva, Switzerland, 1991.
9. JECFA. Evaluation of Certain Food Additives and Contaminants: Ochratoxin A, WHO Technical Report Series 859; WHO: Geneva, Switzerland, 1995.
10. JECFA. Evaluation of Certain Mycotoxins in Food: Ochratoxin A; WHO Technical Report Series 906; WHO: Geneva, Switzerland, 2002.
11. JFAO/WHO Expert Committee on Food Additives. Toxicological Evaluation of Certain Food Additives, WHO Feed Additives Series; JFAO/WHO Expert Committee on Food Additives: Geneva, Switzerland, 1997.
12. JECFA. Evaluation of Certain Food Additives and Contaminants, WHO Technical Report Series, 947: Geneva, Switzerland, 2007.
13. JECFA. Ochratoxin A (addendum). In WHO Food Additive Series 59: Safety Evaluations of Certain Food Additives and Contaminants; IPCS, WHO: Geneva, Switzerland, 2008.
14. Ringot, D.; Chango, A.; Schneider, Y.; Larondelle, Y. Toxicokinetics and toxicodynamics of ochratoxin A, an update. Chem. Biol. Interact. 2006, 159, 18-46.
15. Pfohl-Leszkowicz, A.; Manderville, R.A. Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans. Mol. Nutr. Food Res. 2007, 51, 61-99.
16. Faucet-Marquis, V.; Pont, F.; Størmer, F.C.; Rizk, T.; Castegnaro, M.; Pfohl-Leszkowicz, A. Evidence of a new dechlorinated ochratoxin A derivative formed in opossum kidney cell cultures after pretreatment by modulators of glutathione pathways: Correlation with DNA-adduct formation. Mol. Nutr. Food Res. 2006, 50, 530-542.
17. Tozlovanu, M.; Faucet-Marquis, V.; Pfohl-Leszkowicz, A.; Manderville, R.A. Genotoxicity of the hydroquinone metabolite of ochratoxin a: Structure-activity relationships for covalent DNA adduction. Chem. Res. Toxicol. 2006, 19, 1241-1247.
18. Hadjeba-Medjdoub, K.; Tozlovanu, M.; Pfohl-Leszkowicz, A.; Frenette, C.; Paugh, R.J.; Manderville, R.A. Structure-activity relationships imply different mechanisms of action for Ochratoxin A-mediated cytotoxicity and genotoxicity. Chem. Res. Toxicol. 2012, 25, 181-190.
19. Duarte, S.C.; Pena, A.; Lino, C.M. A review on ochratoxin A occurrence and effects of processing of cereal and cereal derived food products. Food Microbiol. 2010, 27, 187-198.
20. Boorman, G.A.; McDonald, M.R.; Imoto, S.; Persing, R. Renal lesions induced by ochratoxin A exposure in the F344 rat. Toxicol. Pathol. 1992, 20, 236-245.
21. Castegnaro, M.; Mohr, U.; Pfohl-Leszkowicz, A.; Esteve, J.; Steinmann, J.; Tillmann, T.; Michelon, J.; Bartsch, H. Sex- and strain-specific induction of renal tumors by ochratoxin A in rats correlates with DNA adduction. Int. J. Cancer 1998, 77, 70-75.
22. Bendele, A.M.; Carlton, W.W.; Krogh, P.; Lillehoj, E.B. Ochratoxin A carcinogenesis in the (C57BL/6J X C3H) F1 mouse. J. Natl. Cancer Inst. 1985, 75, 733-742.
23. Bozic, Z.; Duancic, V.; Belicza, M.; Kraus, O.; Skljarov, I. Balkan endemic nephropathy: Still a mysterious disease. Eur. J. Epidemiol. 1995, 11, 235-238.
24. Pfohl-Leszkowicz, A.; Petkova-Bocharova, T.; Chernozemsky, I.N.; Castegnaro, M. Balkan endemic nephropathy and associated urinary tract tumors: A review on aetiological causes and the potential role of mycotoxins. Food Addit. Contam. 2002, 19, 282-302.
25. Pfohl-Leszkowicz, A.; Tozlovanu, M.; Manderville, R.; Peraica, M.; Castegnaro, M.; Stefanovic, V. New molecular and field evidences for the implication of mycotoxins but not aristolochic acid in Human Nephropathy and Urinary tract tumor. Mol. Nutr. Food Res. 2007, 51, 131-146.
26. Pfohl-Leszkowicz, A. Ochratoxin A and aristolochic acid involvement in nephropathies and associated urothelial tract tumors. Arh. Hig. Rada Toksikol. 2009, 60, 465-483.
27. Miletic'-Mednev, M. Prevalence of endemic nephropathy and utothelial cancer in Croatia. In Symposium on Recent Advances in Endemic Nephropathy: The Role of Toxins in an Environmental Disease, Zagreb, Croatia, 20-22October 2006.
28. Grollman, A.P.; Jelaković, B. Role of environmental toxins in endemic (Balkan) nephropathy. J. Am. Soc. Nephrol. 2007, 18, 2817-2823.
29. Grollman, A.P.; Shibutani, S.; Moriya, M.; Miller, F.; Wu, L.; Moll, U.; Suzuki, N.; Fernandes, A.; Rosenquist, T.; Medverec, Z. et al. Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc. Natl. Acad. Sci. USA 2007, 104, 12129-12134.
30. Krogh, P. Epidemiology of mycotoxic porcine nephropathy. Nord. Vet. Med. 1976, 28, 452-458.
31. Fink-Gremmels, J. Conclusions from the workshops on Ochratoxin A in Food: Recent developments and significance, organized by ILSI Europe in Baden (Austria), 29 June-1 July 2005. Food Addit. Contam. 2005, 22 (Suppl. 1), 1-5.
32. EFSA. Opinion of the Scientific Panel on Contaminants in the food chain on a request from the commission related to Ochratoxin A in Food. EFSA J. 2006, 365, 1-56.
33. JECFA. Ochratoxin A, WHO Technical Report Series 947; IPCS, WHO: Geneva, Switzerland, 2007; pp. 169-180.
34. Cavin, C.; Delatour, T.; Marin-Kuan, M.; Fenaille, F.; Holzhauser, D.; Guignard, G.; Bezencxon, C.; Piguet, D.; Parisod, V.; Richoz-Payot, J. et al. Ochratoxin A-Mediated DNA and protein damage: Roles of nitrosative and oxidative stresses. Toxicol. Sci. 2009, 11, 84-94.
35. Russo, A.; la Fauci, L.; Acquaviva, R.; Campisi, A.; Raciti, G.; Scifo, C.; Renis, M.; Galvano, G.; Vanella, A.; Galvano, F. Ochratoxin A-induced DNA damage in human fibroblast: Protectiveeffect of cyanidin 3-O-β-D-glucoside. J. Nutr. Biochem. 2005, 16, 31-37.
36. Arbillaga, L.; Azqueta, A.; van Delft, J.H.; de Cerain, A.L. In vitro gene expression data supporting a DNA non-reactive genotoxic mechanism for ochratoxin A. Toxicol. Appl. Pharmacol. 2007, 220, 216-224.
37. Pfohl-Leszkowicz, A.; Manderville, R.A. An update on direct genotoxicity as a molecular mechanism of ochratoxin a carcinogenicity. Chem. Res. Toxicol. 2012, 25, 252-262.
38. Fusi, E.; Rebucci, R.; Pecorini, C.; Campagnoli, A.; Pinotti, L.; Saccone, F.; Cheli, F.; Purup, S.; Sejrsen, K.; Baldi, A. Alpha-tocopherol counteracts the cytotoxicity induced by ochratoxin a in primary porcine fibroblasts. Toxins 2010, 2, 1265-1278.
39. Boesch-Saadatmandi, C.; Loboda, A.; Jozkowicz, A.; Huebbe, P.; Blank, R.; Wolffram, S.; Dulak, J.; Rimbach, G. Effect of ochratoxin A on redox-regulated transcription factors, antioxidant enzymes and glutathione-S-transferase in cultured kidney tubulus cells. Food Chem. Toxicol. 2008, 46, 2665-2671.
40. Malekinejad, H.; Farshid, A.A.; Mirzakhani, N. Liquorice plant extract reduces ochratoxin A-induced nephrotoxicity in rats. Exp. Toxicol. Pathol. 2011, 63, 125-130.
41. O'Brien, E.; Dietrich, D.R. Ochratoxin A: The continuing enigma. Crit. Rev. Toxicol. 2005, 35, 33-60.
42. Gautier, J.C.; Holzhaeuser, D.; Markovoc, J.; Gremaud, E.; Schilter, B.; Turesky, R.J. Oxidative damage and stress response from ochratoxin A exposure in rats. Free Radic. Biol. Med. 2001, 30, 1089-1098.
43. Schaaf, G.J.; Nijmeijer, S.M.; Maas, R.F.; Roestenberg, P.; de Groene, E.M.; Fink-Gremmel, J. The role of oxidative stress in the ochratoxin A-mediated toxicity in proximal tubular cells. Biochim. Biophys. Acta 2002, 1588, 149-158.
44. Gillman, I.G.; Clark, T.N.; Manderville, R.A. Oxidation by ochratoxin A by an Fe-porphyrin system: Model for enzymatic activation and DNA cleavage. Chem. Res. Toxicol. 1999, 12, 1066-1076.
45. Hoehler, D.; Marquardt, R.R.; McIntosh, A.R.; Xiao, H. Free radical generation as induced by ochratoxin A and its analogs in bacteria (Bacillus brevis). J. Biol. Chem. 1996, 271, 27388-27394.
46. Hoehler, D.; Marquardt, R.R.; McIntosh, A.R.; Hatch, G.M. Induction of free radicals in hepatocytes, mitochondria and microsomes of rats by ochratoxin A and its analogs. Biochim. Biophys. Acta 1997, 1357, 225-233.
47. Rahimtula, A.D.; Bereziat, J.C.; Bussacchini-Griot, V.; Bartsch, H. Lipid peroxidation as a possible cause of ochratoxin A toxicity. Biochem. Pharmacol. 1988, 37, 4469-4477.
48. Pfohl-Leszkowicz, A.; Grosse, Y.; Kane, A.; Gharbi, A.; Baudrimont, I.; Obrecht, S.; Creppy, E.E.; Dirheimer, G. Is the Oxydative Pathway Implicated in the Genotoxicity of Ochratoxin A? In Human Ochratoxicosis and Related Pathologies; Creppy, E., Castegnaro, M., Dirheimer, G., Eds.; John Lib-bey Eurotex, Colloque INSERM: Montrouge, France, 1993; Volume 231, pp. 177-187.
49. Baudrimont, I.; Betbeder, A.M.; Gharbi, A.; Pfohl-Leszkowicz, A.; Dirheimer, G.; Creppy, E.E. Effect of superoxide dismutase and catalase on the nephrotoxicity induced by subchronical administration of ochratoxin A in rats. Toxicology 1994, 89, 101-111.
50. Grosse, Y.; Chekir-Ghedira, L.; Huc, A.; Obrecht-Pflumio, S.; Dirheimer, G.; Bacha, H.; Pfohl-Leszkowicz, A. Retinol, ascorbic acid and α-tocopherol prevent DNA adduct formation in mice treated with the mycotoxins ochratoxin A and zearalenone. Cancer Lett. 1997, 114, 225-229.
51. Pfohl-Leszkowicz, A.; Bartsch, H.; Azémar, B.; Mohr, U.; Estève, J.; Castegnaro, M. MESNA protects rats against nephrotoxicity but not carcinogenity induced by Ochratoxin A, implicating two separate pathways. Facta Univ. Ser.: Med. Biol. 2002, 9, 57-63.
52. De Groene, E.M.; Hassing, I.G.; Blom, M.J.; Seinen, W.; Fink-Gremmels, J.; Horback, G.J. Development of human cytochrome P450-expressing cell lines, application in mutagenicity testing of ochratoxin A. Cancer Res. 1996, 56, 299-304.
53. Omar, R.F.; Hasimoff, B.B.; Mejilla, F.; Rahimtula, A.D. Mechanism of ochratoxin A stimulated lipid peroxidation. Biochem. Pharmacol. 1990, 40, 1183-1191.
54. Baudrimont, I.; Betbeder, A.M.; Creppy, E.E. Reduction of the ochratoxin A-induced cytotoxicity in Vero-cells by aspartame. Arch. Toxicol. 1997, 71, 290-298.
55. Belmadani, A.; Steyn, P.S.; Tramu, G.; Betbeder, A.M.; Baudrimont, I.; Creppi, E.E. Selective toxicity of ochratoxin A in primary culture from different brain regions. Arch. Toxicol. 1999, 73, 108-114.
56. Kamp, H.G.; Eisenbrand, G.; Schlatter, J.; Wurth, K.; Janzowski, C. Ochratoxin A: Induction of (oxidative) DNA damage, cytotoxicity and apoptosis in mammalian cell lines and primary cells. Toxicology 2005, 206, 413-425.
57. Xiao, H.; Madhyastha, S.; Marquardt, R.R.; Li, S.; Vodela, J.K.; Frohlich, A.A.; Kemppainen, B.W. Toxicity of ochratoxin A, its opened lactone form and several of its analogs: Structure-activity relationships. Toxicol. Appl. Pharmacol. 1996, 137, 182-192.
58. Dai, J.; Park, G.; Wright, M.W.; Adams, M.; Akman, S.A.; Manderville, R.A. Detection and characterization of a glutathione conjugate of ochratoxin A. Chem. Res. Toxicol. 2002, 15, 1581-1588.
59. Manderville, R.A.; Pfohl-Leszkowicz, A. Chapter 4 genotoxicity of chlorophenols and ochratoxin A. Adv. Mol. Toxicol. 2006, 1, 85-138.
60. Manderville, R.A.; Pfohl-Leszkowicz, A. Bioactivation and DNA adduction as a rationale for ochratoxin A carcinogenesis. World Mycotoxin J. 2008, 1, 357-367.
61. Di Giacomo, C.; Acquaviva, R.; Piva, A.; Sorrenti, V.; Vanella, L.; Piva, G.; Casadei, G.; la Fauci, L.; Ritieni, A.; Bognanno, M. et al. Protective effect of cyanidin 3-O-β-D-glucoside on ochratoxin A-mediated damage in the rat. Br. J. Nutr. 2007, 98, 937-943.
62. Chinje, E.C.; Stratford, I.J. Role of nitric oxide in growth of solid tumors: A balancing act. Essays Biochem. 1997, 32, 61-72.
63. Griffioen, A.W.; Molema, G. Angiogenesis: Potentials or pharmacologic intervention in the treatment of cancer; cardiovascular diseas and crhonic inflammation. Pharm. Rev. 2000, 52, 237-268.
64. Chen, G.G.; Lee, T.W.; Xu, H.; Yip, J.H.; Li, M.; Mok, T.S.; Yim, A.P. Increased inducible nitric oxide synthase in lung carcinoma of smokers. Cancer 2008, 112, 372-381.
65. Lukes, P.; Pàcovà, H.; Kucera, T.; Vesely, D.; Martinek, J.; Asti, J. Expression of endothelial and inducible nitric oxide synthase and caspase-3 in tonsillar cancer; chronic tonsillitis and healthy tonsils. Folia Biol. 2008, 5, 141-145.
66. Brennan, P.A.; Palacios-Callender, M.; Zaki, G.A.; Spedding, A.V.; Langdon, J.D. Type II nitric oxide synthase (NOS2) expression correlates with lynphnode status in oral squamous carcinoma. J. Oral Pathol. Med. 2001, 30, 129-134.
67. Lim, K.H.; Ancrile, B.B.; Kashatus, D.F.; Counter, C.M. Tumour maintenance is mediated by eNOS. Nature 2008, 452, 646-649.
68. Shang, Z.J.; Li, J.R. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: Its correlation with angiogenesis and disease progression. J. Oral Pathol. Med. 2005, 34, 134-139.
69. Kostourou, V.; Robinson, S.P.; Cartwright, J.E.; Whitley, G.S. Dimethylarginine dimethylaminohydrolase I enhances tumour growth and angiogenesis. Br. J. Cancer 2002, 87, 673-680.
70. Leiper, J.; Santa Maria, J.; Chubb, A.; MacAllister, R.J.; Charles, I.G.; Whithley, G.S.J.; Vallance, P. Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology to microbial arginine deiminases. Biochem. J. 1999, 343, 209-214.
71. Nijveldt, R.J.; Teerlink, T.; van Guldener, C.; Prins, H.A.; van Lambalgen, A.A.; Stehouwer, C.D.; Rauwerda, J.A.; van Leeuwen, P.A. Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia. Nephrol. Dial. Transplant. 2003, 18, 2542-2550.
72. Tran, C.T.; Fox, M.F.; Vallance, P.; Leiper, J.M. Chromosomal localization; gene structure; and expression pattern of DDAH1: Comparison with DDAH2 and implications for evolutionary origins. Genomics 2000, 68, 101-105.
73. Sorrenti, V.; di Giacomo, C.; Acquaviva, R.; Bognanno, M.; Grilli, E.; D'Orazio, N.; Galvano, F. Dimethylarginine dimethylaminohydrolase/nitric oxidesynthase pathway in liver and kidney: Protective effect of cyanidin 3-O-β-D-glucoside on ochratoxin-A toxicity. Toxins 2012, 4, 353-363.
74. Gekle, M.; Sauvant, C.; Schwerdt, G. Ochratoxin A at nanomolar concentrations: A signal modulator in renal cells. Mol. Nutr. Food Res. 2005, 49, 118-130.
75. Gagliano, N.; Doone, I.D.; Torri, C.; Migliori, M.; Grizzi, F.; Milzani, A.; Filippi, C.; Annoni, G.; Colombo, P.; Costa, F. et al. Early cytotoxic effects of ochratoxin A in rat liver: A morphological, biochemical and molecular study. Toxicology 2006, 225, 214-224.
76. Stoev, S.D. Studies on carcinogenic and toxic effects of ochratoxin A in chicks. Toxins 2010, 2, 649-664.
77. Vettorazzi, A.; de Trocóniz, I.F.; González-Peñas, E.; Arbillaga, L.; Corcuera, L.A.; Gil, A.G.; de Cerain, A.L. Kidney and liver distribution of ochratoxin A in male and female F344 rats. Food Chem. Toxicol. 2011, 49, 1935-1942.
78. Ferrante, M.C.; Mattace Raso, G.; Bilancione, M.; Esposito, E.; Iacono, A.; Meli, R. Differential modification of inflammatory enzymes in J774A.1 macrophages by ochratoxin A alone or in combination with lipopolysaccharide. Toxicol. Lett. 2008, 181, 40-46.
79. Radi, R. Nitric oxide, oxidants, and protein tyrosine nitration. Proc. Natl. Acad. Sci. USA 2004, 101, 4003-4008.
80. Schilter, B.; Marin-Kuan, M.; Delatour, T.; Nestler, S.; Mantle, P.; Cavin, C. Ochratoxin A: Potential epigeneticmechanisms of toxicity and carcinogenicity. Food Addit. Contam. 2005, 22, 88-93.
81. Kuiper-Goodman, T.; Hilts, C.; Billiard, S.M.; Kiparissis, Y.; Richard, I.D.K.; Hayward, S. Health risk assessment of ochratoxin a for all age-sex strata in a market economy. Food Addit. Contam. 2010, 27, 212-240.
82. Manderville, R.A. A case for the genotoxicity of ochratoxin a by bioactivation and covalent DNA adduction. Chem. Res. Toxicol. 2005, 18, 1091-1097.
83. Turesky, R.J. Perspective: Ochratoxin A is not a genotoxic carcinogen. Chem. Res. Toxicol. 2005, 18, 1082-1090.
84. Petrik, J.; Zanic-Grubisic, T.; Barisic, K.; Pepeljnjak, S.; Radic, B.; Ferencic, Z.; Cepelak, I. Apoptosis and oxidative stress induced by ochratoxin-A in rat kidney. Arch. Toxicol. 2003, 77, 685-693.
85. Kuczuk, M.H.; Benson, P.M.; Heath, H.; Hayes, A.W. Evaluation of the mutagenic potential of mycotoxins using Salmonella typhimurium and Saccharomyces cerevisiae. Mutat. Res. 1978, 53, 11-20.
86. Wehner, F.C.; Thiel, P.G.; van Reusburg, S.J.; Demasius, P.C. Mutagenicity to Salmonella typhimurium of some Aspergillus and Penicillium mycotoxins. Mutat. Res. 1978, 58, 193-203.
87. Bendele, A.M.; Neal, S.B.; Oberly, T.J.; Thompson, C.Z.; Bewsey, B.; Hill, L.E.; Rexroat, M.A.; Carlton, W.W.; Probst, G.S. Evaluation of ochratoxin A for mutagenicity in a battery of bacterial and mammalian cell assay. Food Chem. Toxicol. 1985, 23, 911-918.
88. Würgler, F.E.; Friederich, U.; Schlatter, J. Lack of mutagenicity of ochratoxin A and B, citrinin, patulin and cnestine in Salmonella typhimurium TA102. Mutat. Res. 1991, 261, 209-216.
89. Sakai, M.; Abe, K.I.; Okumura, H.; Kawamura, O.; Sugiura, Y.; Horie, Y.; Ueno, Y. Genotoxicity of fungi evaluated by SOS microplate assay. Nat. Toxins 1992, 1, 27-34.
90. Henning, A.; Fink-Gremmels, J.; Leistner, L. Mutagenicity and Effects of Ochratoxin A on the Frecuency of Sister Chromatid Exchange after Metabolic Activation. IARC Sci. Publ. 1991, 115, 255-260.
91. Obrecht-Pflumio, S.; Chassat, T.; Dirheimer, G.; Marzin, D. Genotoxicity of ochratoxin A by Salmonella mutagenicity test after bioactivation by mouse kidney microsomas. Mutat. Res. 1999, 446, 95-102.
92. Mori, H.; Kawai, K.; Ohbayashi, F.; Kuniyasu, T.; Yamazaki, M.; Hamasaki, T.; Williams, G.M. Genotoxicity of a variety of mycotoxins in the hepatocyte primary culture/DNA repair test using rat and mouse hepatocytes. Cancer Res. 1984, 44, 2918-2923.
93. Dörrenhaus, A.; Föllmann, W. Effects of ochratoxin A on DNA repair in cultures of rat hepatocytes and porcine urinary bladder epithelial cells. Arch. Toxicol. 1997, 71, 709-713.
94. Faucet, V.; Pfohl-Leszkowicz, A.; Dai, J.; Castegnaro, M.; Manderville, R.A. Evidence for covalent DNA adduction by ochratoxin A following chronic exposure to rat and subacute exposure to pig. Chem. Res. Toxicol. 2004, 17, 1289-1296.
95. Mantle, P.G.; Faucet-Marquis, V.; Manderville, R.A.; Squillaci, B.; Pfohl-Leszkowicz, A. Structures of covalent adducts between DNA and ochratoxin A: A new factor in debate about genotoxicity and human risk assessment. Chem. Res. Toxicol. 2010, 23, 89-98.
96. Pfohl-Leszkowicz, A.; Castegnaro, M. Further arguments in favour of direct covalent binding of Ochratoxin A (OTA) after metabolic biotransformation. Food Addit. Contam. 2005, 22, 75-87.
97. Schlatter, C.; Studer-Rohr, C.J.; Rasonyi, T. Carcinogenicity and kinetic aspects of ochratoxin A. Food Addit. Contam. 1996, 13, 43-44.
98. Delatour, T.; Mally, A.; Richoz, J.; Ozden, S.; Dekant, W.; Ihmels, H.; Otto, D.; Gasparutto, D.; Marin-Kuan, M.; Schilter, B. et al. Absence of 2'-deoxyguanosine-carbon 8-bound ochratoxin A adduct in rat kidney DNA monitored by isotope dilution LC-MS/MS. Mol. Nutr. Food Res. 2008, 52, 472-482.
99. Pfohl-Leszkowicz, A.; Gabryelski, W.; Manderville, R.A. Formation of 2'-deoxyguanosine-carbon 8-bound ochratoxin A adduct in rat kidney DNA. Mol. Nutr. Food Res. 2009, 53, 154-155.
100. Mally, A.; Pepe, G.; Ravoori, S.; Fiore, M.; Gupta, R.C.; Dekant, W.; Mosesso, P. Ochratoxin A causes DNA damage and cytogenetic effects but no DNA adducts in rats. Chem. Res. Toxicol. 2005, 18, 1253-1261.
101. Creppy, E.E.; Kane, A.; Dirheimer, G.; Lafarge-Frayssinet, C.; Mousset, S.; Frayssinet, C. Genotoxicity of ochratoxin A in mice: DNA single-strand break evaluation in spleen, liver and kidney. Toxicol. Lett. 1985, 28, 29-35.
102. Kane, A.; Creppy, E.E.; Roth, A.; Roschenthaler, R.; Dirheimer, G. Distribution of the (3H)-label from low doses of radioactive ochratoxin A ingested by rats, and evidence for DNA single-strand breaks caused in liver and kidneys. Arch. Toxicol. 1986, 58, 219-224.
103. Ehrlich, V.; Darroudi, F.; Uhl, M.; Steinkellner, H.; Gann, M.; Majer, B.J.; Eisenbauer, M.; Knasmüller, S. Genotoxic effects of ochratoxin A in human-derived hepatoma (HepG2) cells. Food Chem. Toxicol. 2002, 40, 1085-1090.
104. Lebrun, S.; Follmann, W. Detection of ochratoxin A-induced DNA damage in MDCK cells by alcaline single-cell gel electrophoresis (comet assay). Arch. Toxicol. 2002, 75, 734-741.
105. Degen, G.H.; Gerber, M.M.; Obrecht-Pflumio, S.; Dirheimer, G. Induction of micronuclei with ochratoxin A in ovine seminal vesicle cell cultures. Arch. Toxicol. 1997, 71, 365-371.
106. Dopp, E.; Muller, J.; Hahnel, C.; Schiffmann, D. Induction of genotoxic effects and modulation of the intracellular calcium level in syrian hamster embryo (SHE) fibroblast caused by ochratoxin A. Food Chem. Toxicol. 1999, 37, 713-721.
107. Arbillaga, L.; Azqueta, A.; Ezpeleta, O.; Lopez de Cerain, A. Oxidative DNA damage induced by Ochratoxin A in the HK-2 human kidney cell line: Evidence of the relationship with cytotoxicity. Mutagenesis 2007, 22, 35-42.
108. Tozlovanu, M.; Canadas, D.; Pfohl-Leszkowicz, A.; Frenette, C.; Paugh, R.J.; Manderville, R.A. Glutathione conjugates of ochratoxin A as biomarkers of exposure. Arh. Hig. Rada Toksikol. 2012, 63, 417-427.
109. WHO. Safety evaluation of certain mycotoxins in food. Prepared by 49th meeting of JECFA, WHO Food Additives Series: 47; WHO: Geneva, Switzerland, 1998.
110. Abel, E.L.; Angel, J.M.; Kiguchi, K.; Digiovanni, J. Multi-stage chemical carcinogenesis in mouse skin: Fundamentals and applications. Nat. Protoc. 2009, 4, 1350-1362.
111. Kumar, R.; Ansari, K.M.; Chaudhari, B.P.; Dhawan, A.; Dwivedi, P.D.; Jain, S.K.; Das, M. Topical application of ochratoxin A causes DNA damage and tumor initiation in mouse skin. PLoS One 2012, 7, e47280.
112. Poirier, M.C. Chemical-induced DNA damage and human cancer risk. Nat. Rev. Cancer 2004, 4, 630-637.
113. Grosse, Y.; Baudrimont, I.; Castegnaro, M.; Betbeder, A.M.; Creppy, E.E.; Dirheimer, G.; Pfohl-Leszkowicz, A. Ochratoxin A metabolites and DNA-adducts formation in Monkey kidney cell. Chem. Biol. Interact. 1995, 95, 175-187.
114. Grosse, Y.; Monje, M.C.; Mace, K.; Pfeifer, A.M.; Pfohl-leszkowicz, A. Use of bronchial epithelial cells expressing human cytochrome P450 for study on metabolism and genotoxicity of ochratoxin A. In Vitro Toxicol. 1997, 10, 93-102.
115. Pfohl-Leszkowicz, A.; Pinelli, E.; Bartsch, H.; Mohr, U.; Castegnaro, M. Sex and Strain differences in ochratoxin A metabolism and DNA adduction in two strains of rats. Mol. Carcinog. 1998, 23, 76-83.
116. Jennings Gee, J.E.; Tozlovanu, M.; Manderville, R.; Miller, M.S.; Pfohl-Leszkowicz, A.; Schwartz, G.G. Ochratoxin A: In utero exposure in mice induces adducts in testicular DNA. Toxins 2010, 2, 1428-1444.
117. Marin-Kuan, M.; Ehrlich, V.; Delatour, T.; Cavin, C.; Schilter, B. Evidence for a role of oxidative stress in the carcinogenicity of Ochratoxin A. J. Toxicol. 2011, 2011, 645361.
118. Guerra, M.C.; Galvano, F.; Bonsi, L.; Speroni, E.; Costa, S.; Renzulli, C.; Cervellati, R. Cyanidin-3-O-beta-glucopyranoside, a natural free-radical scavenger against aflatoxin B1- and ochratoxin A-induced cell damage in a human hepatoma cell line (Hep G2) and a human colonic adenocarcinoma cell line (CaCo-2). Br. J. Nutr. 2005, 94, 211-220.
119. Kamp, H.G.; Eisenbrand, G.; Janzowski, C.; Kiossev, J.; Latendresse, J.R.; Schlatter, J.; Turesky, R.J. Ochratoxin A induces oxidative DNA damage in liver and kidney after oral dosing to rats. Mol. Nutr. Food Res. 2005, 49, 160-1167.
120. Cui, J.; Xing, L.; Li, Z.; Wu, S.; Wang, J.; Liu, J.; Wang, J.; Yan, X.; Zhang, X. Ochratoxin A induces G2 phase arrest in human gastric epithelium GES-1 cells in vitro. Toxicol. Lett. 2010, 193, 152-158.
121. National Toxicology Program. Toxicology and carcinogenesis studies of ochratoxin A (CAS No. 303-47-9) in F344/N rats (gavage studies). Natl. Toxicol. Program Tech. Rep. Ser. 1989, 358, 1-142.
122. Petkova-Bocharova, T.; Castegnaro, M.; Pfohl-Leszkowicz, A.; Garren, L.; Grosso, F.; Nikolov, I.; Vrabcheva, T.; Dragacci, S.; Chernozemsky, I.N. Analysis of ochratoxin A in serum and urine of inhabitants from an area with Balkan Endemic Nephropathy: A one month follow up study. Facta Univ. Ser. Med. Biol. 2003, 10, 62-68.
123. Malir, F.; Ostry, V.; Pfohl-Leszkowicz, A.; Roubal, T. Ochratoxin A exposure biomarkers in the Czech Republic and comparison with other countries. Biomarkers 2012, 17, 577-589.
124. Petzinger, E.; Ziegler, K. Ochratoxin A from a toxicological perspective. J. Vet. Pharmacol. Ther. 2000, 23, 91-98.
125. Castegnaro, M.; Canadas, D.; Vrabcheva, T.; Petkova-Bocharova, T.; Chernozemsky, I.N.; Pfohl-Leszkowicz, A. Balkan endemic nephropathy: Role of ochratoxins A through biomarkers. Mol. Nutr. Food Res. 2006, 50, 519-529.
126. Assaf, H.; Azouri, H.; Pallardy, M. Ochratoxin A induces apoptosis in human lymphocytes through down regulation of Bcl-xL. Toxicol. Sci. 2004, 79, 35-344.
127. Liu, J.; Wang, Y.; Cui, J.; Xing, L.; Shen, H.; Wu, S.; Lian, H.; Wang, J.; Yan, X.; Zhang, X. Ochratoxin A induces oxidative DNA damage and G1 phase arrest in human peripheral blood mononuclear cells in vitro. Toxicol. Lett. 2012, 211,164-171.
128. Xu, W.T.; Peng, X.L.; Luo, Y.B.; Wang, J.A.; Guo, X.; Huang, K.L. Physiological and biochemical responses of grapefruit seed extract dip on 'Redglobe' grape. LWT-Food Sci. Technol. 2009, 42, 471-476.
129. Peng, X.L.; Xu, W.T.; Wang, Y.; Huang, K.L.; Liang, Z.H.; Zhao, W.W.; Luo, Y.B. Mycotoxin ochratoxin A-induced cell death and changes in oxidative metabolism of Arabidopsis thaliana. Plant Cell Rep. 2010, 29, 153-161.
130. Gholampour Azizi, I.; Rahimi, K.; Shateri, S. Ochratoxin: Contamination and Toxicity (A Review). Glob. Veterinaria 2012, 8, 519-524.
131. Azzi, A.; Breyer, I.; Feher, M.; Pastori, M.; Ricciarelli, R.; Spycher, S.; Staffieri, M.; Stocker, A.; Zimmer, S.; Zingg, J.M. Specific cellular responses to alpha-tocopherol. J. Nutr. 2000, 130, 1649-1652.
132. Baldi, A. Vitamin E in dairy cows. Livest. Prod. Sci. 2005, 98, 117-122.
133. Azzi, A. Molecular mechanism of α-tocopherol action. Free Radic. Biol. Med. 2007, 43, 16-21.
134. Wang, X.; Quinn, P.J. Vitamin E and its function in membranes. Prog. Lipid Res. 1999, 38, 309-336.
135. Baldi, A.; Losio, M.N.; Cheli, F.; Rebucci, R.; Sangalli, L.; Fusi, E.; Bertasi, B.; Pavoni, E.; Carli, S.; Politis, I. Evaluation of the protective effects of α-tocopherol and retinol against ochratoxin A cytotoxicity. Br. J. Nutr. 2004, 91, 507-512.
136. Cooper, R.; Morre, D.J.; Morre, D.M. Medicinal benefits of green tea: Part I. Review of non cancer health benefits. J. Altern. Complement. Med. 2005, 11, 521-528.
137. Yang, C.S.; Liao, J.; Yang, G.Y.; Lu, G. Inhibitions of lung tumorigenesis by tea. Exp. Lung Res. 2005, 31, 135-144.
138. Takabayashi, F.; Tahara, S.; Kaneko, T.; Harada, N. Effect of green tea catechins on oxidative DNA damage of hamster pancreas and liver induced by N-nitrosobis(2-oxopropyl) amine and/or oxidized soybean oil. Biofactors 2004, 21, 335-337.
139. Rizvi, S.I.; Zaid, M.A.; Anis, R.; Mishra, N. Protective role of tea catechins against oxidation-induced damage of type 2 diabetic erythrocytes. Clin. Exp. Pharmacol. Physiol. 2005, 32, 70-75.
140. Erba, D.; Riso, P.; Bordoni, A.; Foti, P.; Biagi, P.L.; Testolin, G. Effectiveness of moderate green tea consumption on antioxidative status and plasma lipid profile in humans. J. Nutr. Biochem. 2005, 16, 144-149.
141. Hsu, S. Green tea and the skin. J. Am. Acad. Dermatol. 2005, 52, 1049-1059.
142. Costa, S.; Utan, A.; Cervellati, R.; Speroni, E.; Guerra, M.C. Catechins: Natural free-radical scavengers against ochratoxin A-induced cell damage in a pig kidney cell line (LLC-PK1). Food Chem. Toxicol. 2007, 45, 1910-1917.
143. Corcuera, L.A.; Amézqueta, S.; Arbillaga, L.; Vettorazzi, A.; Touriño, S.; Torres, J.L.; López de Cerain, A. A polyphenol-enriched cocoa extract reduces free radicals produced by mycotoxins. Food Chem. Toxicol. 2012, 50, 989-995.
144. Scapagnini, G.; Foresti, R.; Calabrese, V.; Giuffrida Stella, A.M.; Green, C.J.; Motterlini, R. Caffeic acid phenethyl ester and curcumin: A novel class of heme oxygenase-1 inducers. Mol. Pharmacol. 2002, 3, 554-561.
145. Balogun, E.; Hoque, M.; Gong, P.; Kileen, E.; Green, C.J.; Foresti, R.; Alam, J.; Motterlini, R. Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant responsive element. Biochem. J. 2003, 371, 887-895.
146. Motterlini, R.; Foresti, R.; Bassi, R.; Green, C.J. Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase- 1 and protects endothelial cells against oxidative stress. Free Radic. Biol. Med. 2000, 28, 1303-1312.
147. Wang, Z.Y.; Nixon, D.W. Licorice and cancer. Nutr. Cancer 2001, 39, 1-11.
148. Baltina, L.A.; Flekhter, O.B.; Nigmatullina, L.R.; Boreko, E.I.; Pavlova, N.I.; Nikolaeva, S.N.; Savinova, O.V.; Tolstikov, G.A. Lupane triterpenes and derivatives with antiviral activity. Bioorg. Med. Chem. Lett. 2003, 13, 3549-3552.
149. Rauchensteiner, F.; Matsumura, Y.; Yamamoto, Y.; Yamaji, S.; Tani, T. Analysis and comparison of Radix Glycyrrhizae (licorice) from Europe and China by capillary- zone electrophoresis (CZE). J. Pharm. Biomed. Anal. 2005, 38, 594-600.
150. Vaya, J.; Belinky, P.A.; Aviram, M. Antioxidant constituents from licorice roots: Isolation, structure elucidation and antioxidative capacity toward LDL oxidation. Free Radic. Biol. Med. 1997, 23, 302-313.
151. Malekinejad, H.; Mirzakhani, N.; Razi, M.; Cheraghi, H.; Alizadeh, A.; Dardmeh, F. Protective effects of melatonin and Glycyrrhiza glabra extract on ochratoxin A--induced damages on testes in mature rats. Hum. Exp. Toxicol. 2011, 30, 110-123.
152. Jeswal, P. Antidotal effect of grape juice (Vitis vinifera) on ochratoxin A caused hepatorenal carcinogenesis in mice (Mus musculus). Cytobios 1998, 93, 123-128.
153. Rao, A.V.; Agarwal, S. Effect of diet and smoking on serum lycopene and lipid peroxidation. Nutr. Res. 1998, 18, 713-721.
154. Mordente, A.; Guantario, B.; Meucci, E.; Silvestrini, A.; Lombardi, E.; Martorana, G.E.; Giardina, B.; Böhm, V. Lycopene and cardiovascular diseases: An update. Curr. Med. Chem. 2011, 18, 1146-1163.
155. Atessahin, A.; Yilmaz, S.; Karahan, I.; Ceribasi, A.O.; Karaoglu, A. Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats. Toxicology 2005, 212, 116-123.
156. Dogukan, A.; Tuzcu, M.; Agca, C.A.; Gencoglu, H.; Sahin, N.; Onderci, M.; Ozercan, I.H.; Ilhan, N.; Kucuk, O.; Sahin, K. A tomato lycopene complex protects the kidney from cisplatin-induced injury via affecting oxidative stress as well as Bax, Bcl-2, and HSPs expression. Nutr. Cancer 2011, 63, 427-434.
157. Mein, J.R.; Lian, F.; Wang, X.D. Biological activity of lycopene metabolites: Implications for cancer prevention. Nutr. Rev. 2008, 66, 667-683.
158. Wang, Y.; Ausman, L.M.; Greenberg, A.S.; Russell, R.M.; Wang, X.D. Dietary lycopene and tomato extract supplementations inhibit non alcoholic steatohepatitis promoted hepatocarcinogenesis in rats. Int. J. Cancer 2010, 126, 1788-1796.
159. Palabiyik, S.S.; Erkekoglu, P.; Zeybek, N.D.; Kizilgun, M.; Baydar, D.E.; Sahin, G.; Giray, B.K. Protective effect of lycopene against ochratoxin A induced renal oxidative stress and apoptosis in rats. Exp. Toxicol. Pathol. 2013, 65, 853-861.
160. El Adlouni, C.; Pinelli, E.; Azémar, B.; Zaoui, D.; Beaune, P.; Pfohl-Leszkowicz, A. Phenobarbital increases DNA adduct and metabolites formed by ochratoxin A: Role of CYP 2C9 and microsomal glutathione-S-transferase. Environ. Mol. Mutagen. 2000, 35, 123-131.
161. Powell, S.R. The antioxidant properties of zinc. J. Nutr. 2000, 130, 1447S-1454S.
162. Hogstrand, C.; Zinc. In Homeostasis and Toxicology of Essential Metals-Fish Physiology; Wood, C.M., Farrell, A.P., Brauner, C.A., Eds.; Elsevier: San Diego, CA, USA, 2012; pp. 135-200.
163. Zheng, J.; Zhang, Y.; Xu, W.; Luo, Y.; Hao, J.; Shen, X.L.; Yang, X.; Li, X.; Huang, K. Zinc protects HepG2 cells against the oxidative damage and DNA damage induced by ochratoxin A. Toxicol. Appl. Pharmacol. 2013, 268, 123-131.
164. Reiter, R.J. Antioxidant actions of melatonin. Adv. Pharmacol. 1997, 38, 103-117.
165. Linnane, A.W.; Marzuki, S.; Ozawa, T.; Tanaka, M. Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet 1989, 1, 642-645.
166. Yenilmez, A.; Isikli, B.; Aral, E.; Degirmenci, I.; Sutken, E.; Baycu, C. Antioxidant effects of melatonin and coenzyme Q10 on oxidative damage caused by single-dose ochratoxin A in rat kidney. Chin. J. Physiol. 2010, 53, 310-317.
167. Atroshi, F.; Biese, I.; Saloniemi, H.; Ali-Vehmas, T.; Saari, S.; Rizzo, A.; Veijalainen, P. Significance of apoptosis and its relationship to antioxidants after ochratoxin A administration in mice. J. Pharm. Pharm. Sci. 2000, 3, 281-291.